To test this hypothesis, we conducted a prospective study to investigate the association between plasma SDF-1 levels and recurrent stroke, cardiovascular events, and all-cause mortality in ischemic stroke patients based on a large prospective multicenter study of the China Antihypertensive Trial in Acute Ischemic Stroke (CATIS). This evidence concerns the gene CXCL12 and ischemic stroke.